BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 20739083)

  • 21. Expression of matrix metalloproteinase-9 in predicting prognosis of hepatocellular carcinoma after liver transplantation.
    Nart D; Yaman B; Yilmaz F; Zeytunlu M; Karasu Z; KiliƧ M
    Liver Transpl; 2010 May; 16(5):621-30. PubMed ID: 20440771
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic factors affecting survival after recurrence in adult living donor liver transplantation for hepatocellular carcinoma.
    Shin WY; Suh KS; Lee HW; Kim J; Kim T; Yi NJ; Lee KU
    Liver Transpl; 2010 May; 16(5):678-84. PubMed ID: 20440777
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Expression of caveolin-1 gene in hepatitis B-related hepatocellular carcinoma and the clinical significance thereof].
    Yan J; Lu Q; Cai L; Li XW; Dong JH
    Zhonghua Yi Xue Za Zhi; 2008 Dec; 88(46):3272-4. PubMed ID: 19159553
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Relationship between raf kinase inhibitor protein and metastasis of ovarian carcinoma].
    Wang Y; Yang J; Gao Y; Zhao XL; Li HZ; Yao Z
    Zhonghua Fu Chan Ke Za Zhi; 2009 Jul; 44(7):522-8. PubMed ID: 19957553
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The preoperative positivity for serum hepatitis B e antigen did not affect overall survival after curative resection of hepatitis B virus-related hepatocellular carcinoma.
    Choi GH; Kim DH; Choi SB; Kang CM; Kim KS; Choi JS; Lee WJ; Han KH; Chon CY; Kim BR
    J Gastroenterol Hepatol; 2009 Mar; 24(3):391-8. PubMed ID: 19032452
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Raf kinase inhibitor protein mediated signaling inhibits invasion and metastasis of hepatocellular carcinoma.
    Wu X; Yang Y; Xu Z; Li J; Yang B; Feng N; Zhang Y; Wang S
    Biochim Biophys Acta; 2016 Feb; 1860(2):384-91. PubMed ID: 26116914
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduced N-cadherin expression is associated with metastatic potential and poor surgical outcomes of hepatocellular carcinoma.
    Zhan DQ; Wei S; Liu C; Liang BY; Ji GB; Chen XP; Xiong M; Huang ZY
    J Gastroenterol Hepatol; 2012 Jan; 27(1):173-80. PubMed ID: 21777276
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Operative blood loss independently predicts recurrence and survival after resection of hepatocellular carcinoma.
    Katz SC; Shia J; Liau KH; Gonen M; Ruo L; Jarnagin WR; Fong Y; D'Angelica MI; Blumgart LH; Dematteo RP
    Ann Surg; 2009 Apr; 249(4):617-23. PubMed ID: 19300227
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictors of survival after liver transplantation for hepatocellular carcinoma associated with Hepatitis C.
    Shimoda M; Ghobrial RM; Carmody IC; Anselmo DM; Farmer DG; Yersiz H; Chen P; Dawson S; Durazo F; Han S; Goldstein LI; Saab S; Hiatt J; Busuttil RW
    Liver Transpl; 2004 Dec; 10(12):1478-86. PubMed ID: 15558585
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Positive serum hepatitis B e antigen is associated with higher risk of early recurrence and poorer survival in patients after curative resection of hepatitis B-related hepatocellular carcinoma.
    Sun HC; Zhang W; Qin LX; Zhang BH; Ye QH; Wang L; Ren N; Zhuang PY; Zhu XD; Fan J; Tang ZY
    J Hepatol; 2007 Nov; 47(5):684-90. PubMed ID: 17854945
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chemoembolization for hepatocellular carcinoma: multivariate analysis of predicting factors for tumor response and survival in a 362-patient cohort.
    Hu HT; Kim JH; Lee LS; Kim KA; Ko GY; Yoon HK; Sung KB; Gwon DI; Shin JH; Song HY
    J Vasc Interv Radiol; 2011 Jul; 22(7):917-23. PubMed ID: 21571545
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Triple positive tumor markers for hepatocellular carcinoma are useful predictors of poor survival.
    Kiriyama S; Uchiyama K; Ueno M; Ozawa S; Hayami S; Tani M; Yamaue H
    Ann Surg; 2011 Dec; 254(6):984-91. PubMed ID: 21606837
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic values of alpha-fetoprotein and protein induced by vitamin K absence or antagonist-II in hepatitis B virus-related hepatocellular carcinoma: a prospective study.
    Kim HS; Park JW; Jang JS; Kim HJ; Shin WG; Kim KH; Lee JH; Kim HY; Jang MK
    J Clin Gastroenterol; 2009; 43(5):482-8. PubMed ID: 19197197
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictors of survival after resection of early hepatocellular carcinoma.
    Nathan H; Schulick RD; Choti MA; Pawlik TM
    Ann Surg; 2009 May; 249(5):799-805. PubMed ID: 19387322
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HIWI is associated with prognosis in patients with hepatocellular carcinoma after curative resection.
    Zhao YM; Zhou JM; Wang LR; He HW; Wang XL; Tao ZH; Sun HC; Wu WZ; Fan J; Tang ZY; Wang L
    Cancer; 2012 May; 118(10):2708-17. PubMed ID: 21989785
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recurrence of hepatocellular carcinoma and hepatitis B reinfection in hepatitis B surface antigen-positive patients after liver transplantation.
    Saab S; Yeganeh M; Nguyen K; Durazo F; Han S; Yersiz H; Farmer DG; Goldstein LI; Tong MJ; Busuttil RW
    Liver Transpl; 2009 Nov; 15(11):1525-34. PubMed ID: 19877207
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Outcomes after curative treatment for cryptogenic cirrhosis-associated hepatocellular carcinoma satisfying the Milan criteria.
    Takuma Y; Nouso K; Makino Y; Gotoh T; Toshikuni N; Morimoto Y; Shimomura H; Yamamoto H
    J Gastroenterol Hepatol; 2011 Sep; 26(9):1417-24. PubMed ID: 21884248
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overexpression of osteopontin is associated with intrahepatic metastasis, early recurrence, and poorer prognosis of surgically resected hepatocellular carcinoma.
    Pan HW; Ou YH; Peng SY; Liu SH; Lai PL; Lee PH; Sheu JC; Chen CL; Hsu HC
    Cancer; 2003 Jul; 98(1):119-27. PubMed ID: 12833464
    [TBL] [Abstract][Full Text] [Related]  

  • 39. AFP mRNA detected in bone marrow by real-time quantitative RT-PCR analysis predicts survival and recurrence after curative hepatectomy for hepatocellular carcinoma.
    Kamiyama T; Takahashi M; Nakagawa T; Nakanishi K; Kamachi H; Suzuki T; Shimamura T; Taniguchi M; Ozaki M; Matsushita M; Furukawa H; Todo S
    Ann Surg; 2006 Sep; 244(3):451-63. PubMed ID: 16926571
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictors of long-term survival after liver transplantation for hepatocellular carcinoma.
    Zavaglia C; De Carlis L; Alberti AB; Minola E; Belli LS; Slim AO; Airoldi A; Giacomoni A; Rondinara G; Tinelli C; Forti D; Pinzello G
    Am J Gastroenterol; 2005 Dec; 100(12):2708-16. PubMed ID: 16393224
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.